Clinical trial
Exosome as the Prognostic and Predictive Biomarker in EBC Patients
NCT05955521
Study timeline
Study start (actual)2021-05-01Date precision: day
Registry last updated2023-07-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Triple Negative Breast Cancerunresolved
HER2-positive Breast Cancerunresolved
Interventions
exosome and ctDNA evaluationPROCEDURE
Sponsors & collaborators
Samsung Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05955521 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.